Patents by Inventor Verne E. Cowles

Verne E. Cowles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
    Publication number: 20030031711
    Abstract: A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAB receptor agonist such as 4-amino-3-(4-chlorophenyl)butanoic acid, in the evening, in a gastric retained drug delivery system.
    Type: Application
    Filed: May 20, 2002
    Publication date: February 13, 2003
    Inventors: John W. Fara, Bret Berner, Verne E. Cowles
  • Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
    Patent number: 6451808
    Abstract: Metformin is formulated as a pharmaceutical composition that also includes a 5-hydroxytryptamine-3 receptor antagonist to suppress the gastrointestinal side effects that are associated with metformin administration in many patients.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: September 17, 2002
    Assignee: DepoMed, Inc.
    Inventor: Verne E. Cowles